Evidence map›Paper›PMID 23942232›Full record

ArticleThe EMBO journal2013

Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis.

Quan Qiu, Ze Zheng, Lin Chang, Yuan-Si Zhao, Can Tan, Aditya Dandekar, Zheng Zhang, Zhenghong Lin, Ming Gui, Xiu Li and 13 more

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 213 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Inhalation exposure to airborne PMAmerican journal of physiology. Cell physiology · 2025
    Article
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 2 countries.

Quan QiuDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Ze Zheng
Lin Chang
Yuan-Si Zhao
Can Tan
Aditya Dandekar
Zheng Zhang
Zhenghong Lin
Ming Gui
Xiu Li
Tongshuai Zhang
Qingfei Kong
Hulun Li
Sha Chen
An Chen
Randal J Kaufman
Wei-Lei Yang
Hui-Kuan Lin
Donna Zhang
Harris Perlman
Edward Thorp
Kezhong Zhang
Deyu Fang
Northwestern University · USHarbin Medical University · CNWayne State University · USArmy Medical University · CNThe University of Texas MD Anderson Cancer Center · USJimo District Qingdao Hospital of Traditional Chinese Medicine · CNSanford Burnham Prebys Medical Discovery Institute · USUniversity of Arizona · USUniversity of Michigan–Ann Arbor · US

Funding

SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
TRANSGENIC MODELS FOR THE STUDY OF FACTOR V FUNCTIONP01HL057346 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GINSBURG, DAVID · 1997 to 2013
$19.9M
Regulation of Hepatic Steatosis by an ER Stress-Inducible Transcription Factor CRR01DK090313 · NIDDK · WAYNE STATE UNIVERSITY · PI Kezhong Zhang · 2011 to 2026
$5.0M
Role of the Unfolded Protein Response in Beta CellR37DK042394 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2007 to 2016
$4.9M
The roles of Sirt1, a deacetylase, in immune tolerance and autoimmunityR01AI079056 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI FANG, DEYU · 2008 to 2017
$3.3M
A novel target for type 1 diabetesDP2DK083050 · NIDDK · UNIVERSITY OF MISSOURI-COLUMBIA · PI FANG, DEYU · 2008 to 2010
$2.4M
Investigation of an anti-cancer phytochemical targeting Nrf2R01CA154377 · NCI · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2011 to 2015
$1.5M
Unfolded Protein Response in Glucose HomeostasisR01DK042394 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2003 to 2006
$1.2M
Airborne Particulate Matter, Endoplasmic Reticulum Stress and Hepatic Lipid DysreR21ES017829 · NIEHS · WAYNE STATE UNIVERSITY · PI ZHANG, KEZHONG · 2010 to 2011
$442k
The roles of Sirt1, a deacetylase, in immune tolerance and autoimmunityR56AI079056 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FANG, DEYU · 2012 to 2012
$386k
NCI NIH HHS CA154377NCI NIH HHS R01 CA154377NHLBI NIH HHS HL057346NHLBI NIH HHS P01 HL057346NIAID NIH HHS AI079056NIAID NIH HHS R01 AI079056NIAID NIH HHS R56 AI079056NIDDK NIH HHS DK042394NIDDK NIH HHS DK083050NIDDK NIH HHS DK090313NIDDK NIH HHS DP2 DK083050NIDDK NIH HHS R01 DK042394NIDDK NIH HHS R01 DK090313NIDDK NIH HHS R37 DK042394NIEHS NIH HHS ES017829NIEHS NIH HHS P30 ES006694NIEHS NIH HHS R21 ES017829
6 · The paper itself

Abstract

In rheumatoid arthritis (RA), macrophage is one of the major sources of inflammatory mediators. Macrophages produce inflammatory cytokines through toll-like receptor (TLR)-mediated signalling during RA. Herein, we studied macrophages from the synovial fluid of RA patients and observed a significant increase in activation of inositol-requiring enzyme 1α (IRE1α), a primary unfolded protein response (UPR) transducer. Myeloid-specific deletion of the IRE1α gene protected mice from inflammatory arthritis, and treatment with the IRE1α-specific inhibitor 4U8C attenuated joint inflammation in mice. IRE1α was required for optimal production of pro-inflammatory cytokines as evidenced by impaired TLR-induced cytokine production in IRE1α-null macrophages and neutrophils. Further analyses demonstrated that tumour necrosis factor (TNF) receptor-associated factor 6 (TRAF6) plays a key role in TLR-mediated IRE1α activation by catalysing IRE1α ubiquitination and blocking the recruitment of protein phosphatase 2A (PP2A), a phosphatase that inhibits IRE1α phosphorylation. In summary, we discovered a novel regulatory axis through TRAF6-mediated IRE1α ubiquitination in regulating TLR-induced IRE1α activation in pro-inflammatory cytokine production, and demonstrated that IRE1α is a potential therapeutic target for inflammatory arthritis.

Indexed as

AnimalsArthritis, RheumatoidBlotting, WesternCell LineCytokinesDrug Delivery SystemsEndoribonucleasesEnzyme ActivationEnzyme-Linked Immunosorbent AssayGene Expression ProfilingImmunoprecipitationMacrophagesMicePhosphorylationProtein Kinase InhibitorsProtein Serine-Threonine KinasesCytokinesEndoribonucleasesErn1 protein, mouseProtein Kinase InhibitorsProtein Serine-Threonine KinasesTNF Receptor-Associated Factor 6Toll-Like Receptors

Identifiers

PMID23942232
PMCPMC3770952
OpenAlexW2161821256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.